-+ 0.00%
-+ 0.00%
-+ 0.00%

BEAM THERAPEUTICS INC.: PLANS TO ENGAGE FDA ON POTENTIAL PATH TO APPROVAL; ENROLLMENT IN 60 MG DOSE COHORT UNDERWAY

Reuters·10/27/2026 11:02:58

Please log in to view news